Priti Patel

All filings by Priti Patel on record concern Neurogene Inc., in the capacity of senior executive. We count 3 filings; the first trade dates from 30 April 2022 and the latest from 31 March 2023.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The record was last updated on 4 April 2023 with an option exercise in Neurogene Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.